Co-Diagnostics, Inc.

CODX ·Healthcare, Medical Devices, United States

Net Cash Flow Breakdown

FY2022 FY2021 FY2020

Total Cash from Operations: $8.8M

Line Item	Value	% of Total
Capital Expenditures	$1.4M	16.2%
Other Investing	$3.9M	43.6%
Stock Repurchases	$1.3M	14.6%
Working Capital	$2.3M	25.6%
Net Cash Flow	$0	0.0%